[1] GENTILE C L,WEIR T L.The gut microbiota at the intersection of diet and human health[J].Science,2018,362(6416):776-780.
[2] RINNINELLA E,RAOUL P,CINTONI M,et al.What is the healthy gut microbiota composition?A changing ecosystem across age,environment,diet,and diseases[J].Microorganisms,2019,7(1):14.
[3] LI X,ATKINSON M A.The role for gut permeability in the pathogenesis of type 1 diabetes—a solid or leaky concept?[J].Pediatric Diabetes,2015,16(7):485-492.
[4] IMHANN F,VICH VILA A,BONDER M J,et al.Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease[J].Gut,2018,67(1):108-119.
[5] TILG H,ADOLPH T E,GERNER R R,et al.The intestinal microbiota in colorectal cancer[J].Cancer Cell,2018,33(6):954-964.
[6] MUÑOZ L,BORRERO M J,ÚBEDA M,et al.Intestinal immune dysregulation driven by dysbiosis promotes barrier disruption and bacterial translocation in rats with cirrhosis[J].Hepatology,2019,70(3):925-938.
[7] PONZIANI F R,BHOORI S,CASTELLI C,et al.Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease[J].Hepatology,2019,69(1):107-120.
[8] ZUO T,ZHANG F,LUI G C Y,et al.Alterations in gut microbiota of patients with COVID-19 during time of hospitalization[J].Gastroenterology,2020,159(3):944-955.e8.
[9] BROWN A C,VALIERE A.Probiotics and medical nutrition therapy[J].Nutrition in Clinical Care,2004,7(2):56-68.
[10] RHODES J M.Colonic mucus and ulcerative colitis[J].Gut,1997,40(6):807-808.
[11] WANG H Y,LEE I S,BRAUN C,et al.Effect of probiotics on central nervous system functions in animals and humans:a systematic review[J].Journal of Neurogastroenterology and Motility,2016,22(4):589-605.
[12] BROWN K,UWIERA R R E,KALMOKOFF M L,et al.Antimicrobial growth promoter use in livestock:a requirement to understand their modes of action to develop effective alternatives[J].International Journal of Antimicrobial Agents,2017,49(1):12-24.
[13] CHO I,YAMANISHI S,COX L,et al.Antibiotics in early life alter the murine colonic microbiome and adiposity[J].Nature,2012,488(7413):621-626.
[14] LAXMINARAYAN R,DUSE A,WATTAL C,et al.Antibiotic resistance-the need for global solutions[J].The Lancet.Infectious Diseases,2013,13(12):1057-1098.
[15] EARNSHAW S,MENDEZ A,MONNET D L,et al.Global collaboration to encourage prudent antibiotic use[J].The Lancet.Infectious Diseases,2013,13(12):1003-1004.
[16] ALLEN H K,LEVINE U Y,LOOFT T,et al.Treatment, promotion,commotion:antibiotic alternatives in food-producing animals[J].Trends in Microbiology,2013,21(3):114-119.
[17] RASHID M U,WEINTRAUB A,NORD C E.Effect of new antimicrobial agents on the ecological balance of human microflora[J].Anaerobe,2012,18(2):249-253.
[18] BUFFIE C G,PAMER E G.Microbiota-mediated colonization resistance against intestinal pathogens[J].Nature Reviews Immunology,2013,13(11):790-801.
[19] UBEDA C,PAMER E G.Antibiotics, microbiota,and immune defense[J].Trends in Immunology,2012,33(9):459-466.
[20] SPEES A M,LOPEZ C A,KINGSBURY D D,et al.Colonization resistance:battle of the bugs or Ménage à Trois with the host?[J].PLoS Pathogens,2013,9(11):e1003730.
[21] RIVERA-CHÁVEZ F,ZHANG L F,FABER F,et al.Depletion of butyrate-producing clostridia from the gut microbiota drives an aerobic luminal expansion of
Salmonella[J].Cell Host & Microbe,2016,19(4):443-454.
[22] JI S K,JIANG T,YAN H,et al.Ecological restoration of antibiotic-disturbed gastrointestinal microbiota in foregut and hindgut of cows[J].Frontiers in Cellular and Infection Microbiology,2018,8:79.
[23] WOLIN M J.Fermentation in the rumen and human large intestine[J].Science,1981,213(4515):1463-1468.
[24] DE SANTIS S,CAVALCANTI E,MASTRONARDI M,et al.Nutritional keys for intestinal barrier modulation[J].Frontiers in Immunology,2015,6:612.
[25] FARHADI A,BANAN A,FIELDS J,et al.Intestinal barrier:an interface between health and disease[J].Journal of Gastroenterology and Hepatology,2003,18(5):479-497.
[26] LLORENTE C,SCHNABL B.The gut microbiota and liver disease[J].Cellular and Molecular Gastroenterology and Hepatology,2015,1(3):275-284.
[27] PETERSON C T,SHARMA V,ELMÉN L,et al.Immune homeostasis,dysbiosis and therapeutic modulation of the gut microbiota[J].Clinical and Experimental Immunology,2015,179(3):363-377.
[28] DEMEO M T,MUTLU E A,KESHAVARZIAN A,et al.Intestinal permeation and gastrointestinal disease[J].Journal of Clinical Gastroenterology,2002,34(4):385-396.
[29] HARRISON O J,MALOY K J.Innate immune activation in intestinal homeostasis[J].Journal of Innate Immunity,2011,3(6):585-593.
[30] KRAEHENBUHL J P,PRINGAULT E,NEUTRA M R.Review article:intestinal epithelia and barrier functions[J].Alimentary Pharmacology & Therapeutics,1997,11(Suppl 3):3-9.
[31] SCHENK M,MUELLER C.The mucosal immune system at the gastrointestinal barrier[J].Best Practice & Research:Clinical Gastroenterology,2008,22(3):391-409.
[32] KANAI T,ILYAMA R,ISHIKURA T,et al.Role of the innate immune system in the development of chronic colitis[J].Journal of Gastroenterology,2002,37(Suppl 14):38-42.
[33] BISCHOFF S C,BARBARA G,BUURMAN W,et al.Intestinal permeability-a new target for disease prevention and therapy[J].BMC Gastroenterology,2014,14(1):189.
[34] SUZUKI T.Regulation of intestinal epithelial permeability by tight junctions[J].Cellular and Molecular Life Sciences,2013,70(4):631-659.
[35] FARQUHAR M G,PALADE G E.Junctional complexes in various epithelia[J].Journal of Cell Biology,1963,17(2):375-412.
[36] ULLUWISHEWA D,ANDERSON R C,MCNABB W C,et al.Regulation of tight junction permeability by intestinal bacteria and dietary components[J].The Journal of Nutrition,2011,141(5):769-776.
[37] MÉNARD S,CERF-BENSUSSAN N,HEYMAN M.Multiple facets of intestinal permeability and epithelial handling of dietary antigens[J].Mucosal Immunology,2010,3(3):247-259.
[38] KARCZEWSKI J,TROOST F J,KONINGS I,et al.Regulation of human epithelial tight junction proteins by
Lactobacillus plantarum in vivo and protective effects on the epithelial barrier[J].American Journal of Physiology:Gastrointestinal and Liver Physiology,2010,298(6):G851-G859.
[39] UKENA S N,SINGH A,DRINGENBERG U,et al.Probiotic
Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity[J].PLoS One,2007,2(12):e1308.
[40] ZYREK A A,CICHON C,HELMS S,et al.Molecular mechanisms underlying the probiotic effects of
Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair[J].Cellular Microbiology,2007,9(3):804-816.
[41] JOHNSON-HENRY K C,DONATO K A,SHEN-TU G,et al.
Lactobacillus rhamnosus strain GG prevents enterohemorrhagic
Escherichia coli O157∶ H7-induced changes in epithelial barrier function[J].Infection and Immunity,2008,76(4):1340-1348.
[42] PARASSOL N,FREITAS M,THOREUX K,et al.
Lactobacillus casei DN-114001 inhibits the increase in paracellular permeability of enteropathogenic
Escherichia coli-infected T84 cells[J].Research in Microbiology,2005,156(2):256-262.
[43] RESTA-LENERT S,BARRETT K E.Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive
Escherichia coli (EIEC)[J].Gut,2003,52(7):988-997.
[44] EWASCHUK J B,DIAZ H,MEDDINGS L,et al.Secreted bioactive factors from
Bifidobacterium infantis enhance epithelial cell barrier function[J].American Journal of Physiology:Gastrointestinal and Liver Physiology,2008,295(5):G1025-G1034.
[45] ANDERSON R C,COOKSON A L,MCNABB W C,et al.
Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation[J].BMC Microbiology,2010,10:316.
[46] KEBOUCHI M,HAFEEZ Z,LE ROUX Y,et al.Importance of digestive mucus and mucins for designing new functional food ingredients[J].Food Research International,2020,131:108906.
[47] CORFIELD A P,MYERSCOUGH N,LONGMAN R,et al.Mucins and mucosal protection in the gastrointestinal tract:new prospects for mucins in the pathology of gastrointestinal disease[J].Gut,2000,47(4):589-594.
[48] CORNICK S,TAWIAH A,CHADEE K.Roles and regulation of the mucus barrier in the gut[J].Tissue Barriers,2015,3(1/2):e982426.
[49] MACK D R,GAGINELLA T S,SHERMAN P M.Effect of colonic inflammation on mucin inhibition of
Escherichia coli RDEC-1 binding
in vitro[J].Gastroenterology,1992,102(4 Pt 1):1199-1211.
[50] BUISINE M P,DESREUMAUX P,LETEURTRE E,et al.Mucin gene expression in intestinal epithelial cells in Crohn’s disease[J].Gut,2001,49(4):544-551.
[51] GAJENDRAN M,LOGANATHAN P,JIMENEZ G,et al.A comprehensive review and update on ulcerative colitis[J].Disease-a-Month,2019,65(12):100851.
[52] MACK D R,MICHAIL S,WEI S,et al.Probiotics inhibit enteropathogenic
E. coli adherence
in vitro by inducing intestinal mucin gene expression[J].The American Journal of Physiology,1999,276(4):G941-G950.
[53] HAFEZ M M.Upregulation of intestinal mucin expression by the probiotic bacterium
E. coli Nissle 1917[J].Probiotics and Antimicrobial Proteins,2012,4(2):67-77.
[54] MATTAR A F,TEITELBAUM D H,DRONGOWSKI R A,et al.Probiotics up-regulate
MUC-2 mucin gene expression in a Caco-2 cell-culture model[J].Pediatric Surgery International,2002,18(7):586-590.
[55] CABALLERO-FRANCO C,KELLER K,DE SIMONE C,et al.The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells[J].American Journal of Physiology:Gastrointestinal and Liver Physiology,2007,292(1):G315-G322.
[56] CHEN Z C,CEBALLOS-FRANCISCO D,GUARDIOLA F A,et al.Influence of skin wounds on the intestinal inflammatory response and barrier function:protective role of dietary
Shewanella putrefaciens SpPdp11 administration to gilthead seabream (
Sparus aurata L.)[J].Fish & Shellfish Immunology,2020,99:414-423.
[57] DUDÍK B,KIÑOVÁ SEPOVÁ H,BILKA F,et al.Mucin pre-cultivated
Lactobacillus reuteri E shows enhanced adhesion and increases mucin expression in HT-29 cells[J].Antonie van Leeuwenhoek,2020,113(8):1191-1200.
[58] HATO T,DAGHER P C.How the innate immune system senses trouble and causes trouble[J].Clinical Journal of the American Society of Nephrology,2015,10(8):1459-1469.
[59] O’NEILL L A J,GOLENBOCK D,BOWIE A G.The history of Toll-like receptors-redefining innate immunity[J].Nature Reviews.Immunology,2013,13(6):453-460.
[60] KAWAI T,AKIRA S.The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J].Nature Immunology,2010,11(5):373-384.
[61] KAWAI T,AKIRA S.Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J].Immunity,2011,34(5):637-650.
[62] LAMKANFI M,DIXIT V M.Mechanisms and functions of inflammasomes[J].Cell,2014,157(5):1013-1022.
[63] HENAO-MEJIA J,ELINAV E,THAISS C A,et al.Inflammasomes and metabolic disease[J].Annual Review of Physiology,2014,76:57-78.
[64] RATHINAM V A K,VANAJA S K,FITZGERALD K A.Regulation of inflammasome signaling[J].Nature Immunology,2012,13(4):333-342.
[65] LAMKANFI M,DIXIT V M.Inflammasomes and their roles in health and disease[J].Annual Review of Cell and Developmental Biology,2012,28:137-161.
[66] SWANSON K V,DENG M,TING J P Y.The NLRP3 inflammasome:molecular activation and regulation to therapeutics[J].Nature Reviews Immunology,2019,19(8):477-489.
[67] MANGAN M S J,OLHAVA E J,ROUSH W R,et al.Targeting the NLRP3 inflammasome in inflammatory diseases[J].Nature Reviews:Drug Discovery,2018,17(8):588-606.
[68] SCHRODER K,TSCHOPP J.The Inflammasomes[J].Cell,2010,140(6):821-832.
[69] LU F F,LAN Z X,XIN Z Q,et al.Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases[J].Journal of Cellular Physiology,2020,235(4):3207-3221.
[70] ALLEN I C,TEKIPPE E M,WOODFORD R M T,et al.The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer[J].Journal of Experimental Medicine,2010,207(5):1045-1056.
[71] LEE S,NAKAHIRA K,DALLI J,et al.NLRP3 inflammasome deficiency protects against microbial sepsis via increased lipoxin B
4 synthesis[J].American Journal of Respiratory and Critical Care Medicine,2017,196(6):713-726.
[72] LEE H M,KIM J J,KIM H J,et al.Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes[J].Diabetes,2013,62(1):194-204.
[73] MATHEWS R J,ROBINSON J I,BATTELLINO M,et al.Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA);genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment[J].Annals of the Rheumatic Diseases,2014,73(6):1202-1210.
[74] HENEKA M T,KUMMER M P,STUTZ A,et al.NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice[J].Nature,2013,493(7434):674-678.
[75] CHUNG I C,OUYANG C N,YUAN S N,et al.Pretreatment with a heat-killed probiotic modulates the NLRP3 inflammasome and attenuates colitis-associated colorectal cancer in mice[J].Nutrients,2019,11(3):516.
[76] YAN Y,LIU C Y,ZHAO S M,et al.Probiotic
Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease[J].AMB Express,2020,10(1):101.
[77] XIA B,YU J,HE T,et al.
Lactobacillus johnsonii L531 ameliorates enteritis via elimination of damaged mitochondria and suppression of SQSTM1-dependent mitophagy in a Salmonella infantis model of piglet diarrhea[J].FASEB Journal,2020,34(2):2821-2839.
[78] SHENG K L,HE S M,SUN M,et al.Synbiotic supplementation containing
Bifidobacterium infantis and xylooligosaccharides alleviates dextran sulfate sodium-induced ulcerative colitis[J].Food & Function,2020,11(5):3964-3974.
[79] DIGEHSARA S G,NAME N,SARTIPNIA N,et al.Analysis of inflammasomes and CYP27B1 genes in cuprizone demyelinated C57BL/6 mice and evaluation of Th1 and Th2 patterns after oral administration of
Lactobacillus casei strain T2(IBRC-M10783)[J].Microbial Pathogenesis,2021,155:104931.
京公网安备 11010802041926号